ADVANCED COMPUTER-ASSISTED TECHNIQUES IN DRUG DISCOVERY, VOLUME 3

ANIMAL MODELS FOR HUMAN CANCER

ANIMAL MODELS FOR HUMAN CANCER

ANIMAL MODELS FOR HUMAN CANCER

ANIMAL MODELS FOR HUMAN CANCER (HB)

ANTITARGETS

ANTITARGETS AND DRUG SAFETY

ANTITARGETS AND DRUG SAFETY

ANTITARGETS AND DRUG SAFETY

ANTITARGETS AND DRUG SAFETY (HB)

ANTIVIRAL DRUG STRATEGIES (HB)

ANTIVIRAL DRUG STRATEGIES, VOLUME 50

ANTIVIRAL DRUG STRATEGIES, VOLUME 50

ANTIVIRAL DRUG STRATEGIES, VOLUME 50

ASPARTIC ACID PROTEASES AS THERAPEUTIC TARGETS (HB)

ASPARTIC ACID PROTEASES AS THERAPEUTIC TARGETS, VOLUME 45

ASPARTIC ACID PROTEASES AS THERAPEUTIC TARGETS, VOLUME 45

ASPARTIC ACID PROTEASES AS THERAPEUTIC TARGETS, VOLUME 45

BIO-NMR IN DRUG RESEARCH (HB)

BIOISOSTERES IN MEDICINAL CHEMISTRY, VOLUME 54

BIOISOSTERES IN MEDICINAL CHEMISTRY, VOLUME 54

BIOISOSTERES IN MEDICINAL CHEMISTRY, VOLUME 54

BIOISOSTERES IN MEDICINAL CHEMISTRY, VOLUME 54 (HB)

BIONMR IN DRUG RESEARCH, VOLUME 16

CHEMOGENOMICS IN DRUG DISCOVERY

CHEMOINFORMATICS IN DRUG DISCOVERY (HB)

CHEMOINFORMATICS IN DRUG DISCOVERY, VOLUME 23

CHEMOKINE RECEPTORS AS DRUG TARGETS (HB)

CHEMOMETRIC METHODS IN MOLECULAR DESIGN, VOLUME 2

CHIRALITY IN DRUG RESEARCH, VOLUME 33

CHIRALITY IN DRUG RESEARCH, VOLUME 33 (HB)

COMBINATORIAL CHEMISTRY

COMBINATORIAL CHEMISTRY

COMBINATORIAL CHEMISTRY (HB)

DRUG BIOAVAILABILITY

DRUG BIOAVAILABILITY (HB)

DRUG METABOLISM PREDICTION, VOLUME 63

DRUG METABOLISM PREDICTION, VOLUME 63

DRUG METABOLISM PREDICTION, VOLUME 63

DRUG METABOLISM PREDICTION, VOLUME 63 (HB)

DRUG SELECTIVITY

DRUG-MEMBRANE INTERACTIONS

EPIGENETIC TARGETS IN DRUG DISCOVERY

EPIGENETIC TARGETS IN DRUG DISCOVERY (HB)

EPIGENETIC TARGETS IN DRUG DISCOVERY, VOLUME 42 (HB)

EVOLUTIONARY ALGORITHMS IN MOLECULAR DESIGN, VOLUME 8

FRAGMENT-BASED APPROACHES IN DRUG DISCOVERY

FRAGMENT-BASED APPROACHES IN DRUG DISCOVERY, VOLUME 34

FRAGMENT-BASED APPROACHES IN DRUG DISCOVERY, VOLUME 34 (HB)

FRAGMENT-BASED DRUG DISCOVERY

FRAGMENT-BASED DRUG DISCOVERY

FRAGMENT-BASED DRUG DISCOVERY

FRAGMENT-BASED DRUG DISCOVERY (HB)

G PROTEIN-COUPLED RECEPTORS AS DRUG TARGETS

G PROTEIN-COUPLED RECEPTORS AS DRUG TARGETS (HB)

HANDBOOK OF MOLECULAR DESCRIPTORS, VOLUME 11

HIGH-THROUGHPUT SCREENING IN DRUG DISCOVERY

HIGH-THROUGHPUT SCREENING IN DRUG DISCOVERY (HB)

HIGH-THROUGHPUT SCREENING IN DRUG DISCOVERY, VOLUME 35

HIT AND LEAD PROFILING (HB)

IN VIVO MODELS FOR DRUG DISCOVERY (HB)

LEAD GENERATION

LEAD GENERATION

LEAD GENERATION

LEAD GENERATION (HB)

LIGAND DESIGN FOR G PROTEIN-COUPLED RECEPTORS

LIGAND DESIGN FOR G PROTEIN-COUPLED RECEPTORS (HB)

LIGAND DESIGN FOR G PROTEIN-COUPLED RECEPTORS, VOLUME 30

MASS SPECTROMETRY IN MEDICINAL CHEMISTRY

MASS SPECTROMETRY IN MEDICINAL CHEMISTRY

MASS SPECTROMETRY IN MEDICINAL CHEMISTRY (HB)

MEDICINAL CHEMISTRY APPROACHES TO PERSONALIZED MEDICINE (HB)

MEDICINAL CHEMISTRY APPROACHES TO PERSONALIZED MEDICINE, VOLUME 59

MEDICINAL CHEMISTRY APPROACHES TO PERSONALIZED MEDICINE, VOLUME 59

MEDICINAL CHEMISTRY APPROACHES TO PERSONALIZED MEDICINE, VOLUME 59

MICROWAVES IN ORGANIC AND MEDICINAL CHEMISTRY

MICROWAVES IN ORGANIC AND MEDICINAL CHEMISTRY, VOLUME 25

MOLECULAR DESCRIPTORS FOR CHEMOINFORMATICS (HB)

MOLECULAR DESCRIPTORS FOR CHEMOINFORMATICS, VOLUME 41 (2 VOLUME SET)

MOLECULAR DRUG PROPERTIES

MOLECULAR DRUG PROPERTIES (HB)

MOLECULAR INTERACTION FIELDS

MOLECULAR INTERACTION FIELDS (HB)

MOLECULAR MODELING

MOLECULAR MODELING

NATURAL PRODUCTS IN MEDICINAL CHEMISTRY (HB)

NATURAL PRODUCTS IN MEDICINAL CHEMISTRY, VOLUME 60

NATURAL PRODUCTS IN MEDICINAL CHEMISTRY, VOLUME 60

NATURAL PRODUCTS IN MEDICINAL CHEMISTRY, VOLUME 60

NEW TRENDS IN SYNTHETIC MEDICINAL CHEMISTRY, VOLUME 7

NUCLEAR RECEPTORS AS DRUG TARGETS, VOLUME 39

NUCLEAR RECEPTORS AS DRUG TARGETS, VOLUME 39 (HB)

PHARMACOPHORES AND PHARMACOPHORE SEARCHES, VOLUME 32

PHOSPHODIESTERASES AND THEIR INHIBITORS (HB)

PHOSPHODIESTERASES AND THEIR INHIBITORS, VOLUME 61

PHOSPHODIESTERASES AND THEIR INHIBITORS, VOLUME 61

PHOSPHODIESTERASES AND THEIR INHIBITORS, VOLUME 61

PREDICTIVE TOXICOLOGY

PREDICTIVE TOXICOLOGY

PREDICTIVE TOXICOLOGY

PREDICTIVE TOXICOLOGY (HB)

PRODRUGS AND TARGETED DELIVERY

PRODRUGS AND TARGETED DELIVERY

PRODRUGS AND TARGETED DELIVERY

PRODRUGS AND TARGETED DELIVERY (HB)

PROTEIN CRYSTALLOGRAPHY IN DRUG DISCOVERY (HB)

PROTEIN CRYSTALLOGRAPHY IN DRUG DISCOVERY, VOLUME 20

PROTEIN KINASES AS DRUG TARGETS (HB)

PROTEIN THERAPEUTICS (HB)

PROTEIN-LIGAND INTERACTIONS

PROTEIN-LIGAND INTERACTIONS (HB)

PROTEIN-LIGAND INTERACTIONS, VOLUME 53

PROTEIN-LIGAND INTERACTIONS, VOLUME 53

PROTEIN-LIGAND INTERACTIONS, VOLUME 53

PROTEIN-PROTEIN INTERACTIONS IN DRUG DISCOVERY (HB)

PROTEIN-PROTEIN INTERACTIONS IN DRUG DISCOVERY, VOLUME 56

PROTEIN-PROTEIN INTERACTIONS IN DRUG DISCOVERY, VOLUME 56

PROTEIN-PROTEIN INTERACTIONS IN DRUG DISCOVERY, VOLUME 56

QSAR

QUANTUM MEDICINAL CHEMISTRY, VOLUME 17

SCAFFOLD HOPPING IN MEDICINAL CHEMISTRY (HB)

SCAFFOLD HOPPING IN MEDICINAL CHEMISTRY, VOLUME 58

SCAFFOLD HOPPING IN MEDICINAL CHEMISTRY, VOLUME 58

SCAFFOLD HOPPING IN MEDICINAL CHEMISTRY, VOLUME 58

STRUCTURE-BASED LIGAND DESIGN

STRUCTURE-BASED LIGAND DESIGN, VOLUME 6

TARGET DISCOVERY AND VALIDATION (HB)

THERMODYNAMICS AND KINETICS OF DRUG BINDING, VOLUME 65

THERMODYNAMICS AND KINETICS OF DRUG BINDING, VOLUME 65

THERMODYNAMICS AND KINETICS OF DRUG BINDING, VOLUME 65

THERMODYNAMICS AND KINETICS OF DRUG BINDING, VOLUME 65 (HB)

TRANSPORTERS AS DRUG CARRIERS

TRANSPORTERS AS DRUG CARRIERS (HB)

TRANSPORTERS AS DRUG TARGETS (HB)

VIRTUAL SCREENING

VIRTUAL SCREENING

VIRTUAL SCREENING

VIRTUAL SCREENING (HB)